What does ABRDN stand for?
ABRDN stands for African Biomedical Research and Development Network.
What is ABRDN’s goal?
To strengthen Africa’s biomedical research capacity. This will be achieved by ensuring sustainable, long-term financing for Africa’s laboratories, implementing quality control systems, producing high-quality research publications in the fields of biomedical sciences and engineering, and increasing access to knowledge in all areas of the life sciences. These goals are accomplished by implementing innovative solutions to the challenges faced by African biomedical researchers.
ABRDN was founded in 2006 with a grant from the Bill & Melinda Gates Foundation (BMGF) through Frontiers in Innovation (FII).
Where is ABRDN located?
ABRDN is headquartered in Washington, D.C., and has offices in Berkeley, CA, and Port-au-Prince, Haiti.
ABRDN’s mission statement
ABRDN is a grass-roots partnership of scientists and other African researchers committed to developing biomedical research talent and capacity. Its goals are: to increase awareness of emerging biomedical research opportunities; to facilitate access to resources for basic scientific research; and to develop capacities in the areas of clinical science, biotechnology and molecular biology (especially vaccine development), genetic epidemiology, public health genetics, veterinary medicine, and veterinary public health.
What are ABRDN’s programs?
ABRDN provides support through a variety of means, including direct grants to researchers. The Foundation makes available all the resources needed to conduct research, including equipment, research funds, and expertise. One of the more distinctive aspects of ABRDN is the development of problem-solving teams that address specific research needs in Africa, such as developing a vaccine against African trypanosomiasis or determining the origins and evolution of infectious diseases in Africa.
Who are ABRDN’s partners?
ABRDN partners include foreign governments, international foundations, and U.S.-based organizations interested in biomedical science and technology development in sub-Saharan Africa.